London, UK-based Alis Biosciences, an investment fund focused on returning capital to investors that is currently trapped in ...

The US subsidiary of Chinese biotech VelaVigo Cayman Limited has announced its second out-licensing agreement of a ...

The National Board of Health and Welfare will pay 80 million kronor ($8.3 million) to the national initiative Genomic ...

The DESTINY-Breast09 Phase III trial of AstraZeneca (LSE: AZN) and Daiichi Sankyo’s (TYO: 4568) Enhertu (trastuzumab ...

On the research front last week, China-based biotech Remegen released positive Phase III results for its telitacicept in ...

The US Food and Drug Administration (FDA) has granted another approval for Dupixent (dupilumab), for the treatment of adults ...

In keeping with US Department of Health and Human Services Secretary Robert F Kennedy Jr’s promise to carry out the ...

BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, ...

Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...

Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for ...

US cancer drug developer Werewolf Therapeutics today announced the appointment of Steven Bloom as chief business officer ...

Dutch gene therapy company uniQure (Nasdaq: QURE) announced that the US Food and Drug Administration (FDA) has granted ...